Popular Articles
Stretch Mark

Promising Results With Aleglitazar, A New Treatment Drug For Type 2 Diabetes (SYNCHRONY Study)
The results from the phase II SYNCHRONY study are published in an article Online First and in a future edition of The Lancet. At the same time, the findings are presented at the American Diabetes Association meeting in New Orleans, USA. They suggest that aleglitazar, a treatment for type 2 diabetes, might be safe and effective and may perhaps be introduced into phase III trials.
generic viagra online
Kaiser Daily Health Policy Report Feature Highlights Recent Blog Entries
"Blog Watch" offers readers a roundup of health policy-related blog posts.The Congressional Budget Office is making waves: several bloggers are prognosticating about the agency"s forthcoming estimate of the cost of health reform proposals. The New Republic"s Jonathan Cohn reports that he"s hearing the cost estimate could be closer to $1 trillion than the previously discussed $1.5 trillion. However, Cohn notes that the figure does not include employer contributions and could still leave one-quarter to one-third of the uninsured without coverage. Cato"s Michael Cannon interprets last week"s announcement that several industry groups pledged to slow the growth of health care spending as evidence that the real motivation was "to pressure the Congressional Budget Office to assume that Democrats" health care reforms would reduce spending, despite the lack of evidence." (his emphasis) Bob Laszewski also hinted at this with a post titled "An Open Letter to the Men and Women Over at the CBO" that ended: "The only thing standing between BS reform and real reform are the men and women -- real men and real women -- over at the CBO ... Hang in there!!!!" Cannon echoes the sentiment with fewer exclamation points: "The CBO (and everybody else) should resist the Democrats" effort to make truth yield to power." Marginal Revolution"s Tyler Cowen says he"s reviewing "health care cost fallacies" and asks readers to "sign on to" this statement: "The fiscal outlook is grimmer than before, therefore we should spend less on health care reform than I used to think." Ezra Klein, from his new perch at the Washington Post, counters with his own: "The fiscal outlook is grimmer than before, therefore we should agree on more radical health reforms than were previously considered." Klein then links to a Center for Economic and Policy Research graph, which shows the projected deficit as a proportion of the gross domestic product for various industrialized nations. Unsurprisingly, the line for the United States is headed skyward, while those for Canada, France, Germany and England drop. Meanwhile, disputes continue on a public plan option. Families USA President Ron Pollack reminds readers of his support: "As I said last week at the Senate Finance Committtee"s roundtable. ... First, a public plan option would increase choice. Second, it creates a benchmark on cost that is likely to have a positive impact on lowering costs on private plans. Third, the public plan would be a of obtaining important data about health care that is unlikely available through the private plans, and will enable certain improvements in America"s health care system." Yet Jeff Goldsmith on the Health Affairs Blog says that such a plan is "not worth the risks" and advises, "Health reformers would be smart to trade the radioactive "public plan" bargaining chip for concessions from the industry and to focus their attention on finding an employment-friendly financing plan, and on Medicare payment reform." The National Journal"s Marilyn Werber Serafini solicits her experts" opinions: Are we any closer to consensus on a public health plan after Senate Finance Committee Chair Max Baucus (D-Mont.) and ranking member Chuck Grassley (R-Iowa) presented three options for the committee to consider as part of broader health care reform legislation this year? The responders -- Stuart Butler, Karen Davis, Marian Wright Edelman, Uwe Reinhardt and John Sheils -- don"t come to a conclusion. Interesting elsewhere:
News of the day
Don't Forget Your Condoms At Swansea Pride, Says Terrence Higgins Trust Cymru
HIV and sexual health charity Terrence Higgins Trust (THT) Cymru is reminding visitors to Swansea Pride (Saturday 27th June) not to put their sexual health at risk by getting carried away with the party mood.
Mental Health

Bioengineers Develop A Microfabricated Device To Measure Cellular Forces During Tissue Development

A University of Pennsylvania-collaboration of bioengineers studying the physical forces generated by individual cells has created a tiny micron-sized device that allows researchers to measure and manipulate cellular forces as assemblies of living cells reorganize themselves into tissues. The new micro-tool created in the study allows researchers to gauge how cells" minute mechanical forces affect cellular behavior, protein deposition and cell differentiation in a 3-dimensional, in vivo-like environment that mimics how tissue actually forms in a living organism. The finding also has implications for the testing of irregular or diseased tissue, such as beating cardiac tissue, which can be modeled and studied. The findings were published in the June issue of the Proceedings of the National Academy of Sciences. The push-and-pull of cellular forces drives the buckling, extension and contraction of cells that occur during tissue development. These processes that ultimately shape the architecture of tissues play an important role in coordinating cell signaling, gene expression and behavior, and they are essential for wound healing and tissue homeostasis in adult organisms. Yet a detailed picture of how tissue mechanics link to morphogenetic phenomena has been hindered by a lack of model systems in which both mechanics and remodeling can be simultaneously examined. The Penn study highlights a complex and dynamic relationship between cellular forces, visualizes the remodeling of a matrix by living cells and demonstrates a system to study and apply this relationship within engineered 3-D microtissue. Chris Chen, professor of bioengineering in the School of Engineering and Applied Science at Penn, developed the tool with colleagues at the University of California, Santa Barbara, and the University of Cambridge. The system was created using photolithography, the same technology used to craft semiconductors. Scientists fabricated an array of tiny divots within a mold and immersed the mold in a culture of cells and collagen. Researchers then placed raised microcantilever posts on either side of the mold and - much like draping a volleyball net across two metal poles - observed the formation of a cell and collagen web of living tissue anchored to the cantilevers. These microcantilevers were used to simultaneously constrain the remodeling of a collagen gel and to report forces generated during this process. The cantilever posts allowed the team to observe and measure the retraction and extension of the cells as they remodeled the adjacent matrix into a coherent band of tissue. Varying the mechanical stiffness of the cantilevers and collagen matrix demonstrated that the cellular forces increased with boundary or matrix rigidity, whereas the levels of proteins in the cytoskeleton and extracellular matrix also increased with levels of mechanical stress. By mapping these relationships between cellular and matrix mechanics, cellular forces and protein expression onto a bio-chemo-mechanical model of microtissue contractility, the team demonstrated how intratissue gradients of mechanical stress can emerge from collective cellular contractility and, finally, how such gradients can be used to engineer protein composition and organization within a 3-D tissue. "Just as we build muscle in the gym, these same mechanical forces are translated down to the cellular level and build the complex arrangement of different tissues in the body," co-author Wesley Legant said. "By varying the properties of our model system, we can study how these mechanical factors are distributed throughout a tissue and how this can, in turn, effect cellular function." "With this system, we also see the potential for high-throughput drug testing, as researchers will be able to test new pharmaceuticals against a vast array of these small tissue samples, perhaps identifying new ways to increase the contractility of cardiac muscle, or to relax arteries to treat hypertension," said Chen, the study"s lead author. Working with colleagues, the team also created a mathematical model of the entire process that accurately predicted the experimental results. "With this model, we can extend our findings to more complex and realistic model tissues which might be difficult to study experimentally in the lab" Legant said. Notes: The study was conducted by Chen, Legant and Michael T. Yang of the Department of Bioengineering at Penn; Amit Pathak and Robert M. McMeeking of the Department of Mechanical Engineering at UCSB; and Vikram S. Deshpande of the Department of Engineering at Cambridge. The research was funded by grants from the National Institutes of Health, an Army Research Office Multidisciplinary University Research Initiative, the Material Research Science and Engineering Center and Center for Engineering Cells and Regeneration at Penn, the U.S Department of Education"s Graduate Assistance in Areas of National Need and the National Science Foundation"s Graduate Research Fellowship. Jordan Reese University of Pennsylvania


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):